Invus Global Management, Director of Lexicon Pharmaceuticals LXRX, has filed 1 purchase and 15 sales on the open market. Over the past 12 months that comes to a net purchase of $2M. The latest trade was on 02/02.

IM

IM

Invus Global Management

Director

Company

Lexicon Pharmaceuticals LXRX

First filing

24/07/30

Trades

21 trades

Buys / sales

1 / 15

12-month net buying

$2M

Last trade

02/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Lexicon PharmaceuticalsLXRX	Open-market buy	02/02	02/04	1,538,462 sh	$1.30	$2,000,000.6	No record
Scholar Rock HoldingSRRK	Open-market sale	24/12/10	24/12/12	1,600,000 sh	$41.65	$66,640,000	−14.7%
Scholar Rock HoldingSRRK	Open-market sale	24/11/25	24/11/27	409,433 sh5 trades	$38.49avg.	$15,757,297.83	−3.6%
Crescent BiopharmaCBIO	Open-market sale	24/08/07–24/08/08	24/08/09	322,361 sh2 trades	$0.19avg.	$60,633.71	−4.9%
Crescent BiopharmaCBIO	Open-market sale	24/08/05–24/08/06	24/08/07	220,255 sh2 trades	$0.19avg.	$41,291.13	−3.2%
Crescent BiopharmaCBIO	Open-market sale	24/08/01–24/08/02	24/08/05	349,764 sh2 trades	$0.20avg.	$71,224.08	−4.9%
Crescent BiopharmaCBIO	Open-market sale	24/07/26–24/07/30	24/07/30	1,379,119 sh3 trades	$0.23avg.	$315,851.86	−16.1%